Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

A woman with severe angioedema improved significantly after treatment with rituximab.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Dutasteride is more efficient than finasteride, but individual results vary.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride can cause serious side effects in some men, needing more research for treatment.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.